News By Tag
News By Place
Follow on Google News
Partners4access To Attend BIA's Event
The event will take place at IET Savoy Place, London, United Kingdom.
P4A became a member of BIA in June this year. BIA represents several stakeholders within the biosciences area from small clinical stage biotechs, large pharma corporations, academics and service providers to the biotech industry. Their members account for majority of biotech drugs currently in clinical development. BIA is a leading voice in highlighting the UK life science industry's challenges in innovation, research and development.
Sophie Schmitz, Managing Partner said, "BIA's event is a unique peer to peer networking forum enabling discussions in scientific advancements to corporate trends. With our focus on Orphan Drugs, Cell & Gene Therapy, this is a great opportunity for P4A to connect with world class research and development-
P4A are specialists in orphan drug, cell and gene therapy access, partnering with the biotechnology industry to support launches worldwide. Focus areas include: orphan drug, cell and gene thearpy pricing and market access strategy; bespoke access roadmap development;
Through its initiatives, P4A are able to inform and shape the conversation around orphan drugs.
The team at P4A believe in striking an equilibrium in the rare disease world. That means helping drive access to the most appropriate treatments for patients and physicians, a fair return on investment for manufacturers at an affordable proposition for payers.
For more information, please email P4A at email@example.com or visit our website: http://www.partners4access.com
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations;
For further information, please go to www.bioindustry.org